Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug.

We have investigated the biochemical and cell biological basis of the reported beneficiary effects of the leaf extracts of the plant Ginkgo biloba, which has been used as a possible ophthalmic drug. The antioxidant, antimicrobial, anti-apoptotic and cytoprotective properties of the standardized extract called EGb761 were assayed. Chemical stresses were induced in cells using alloxan or dexamethasone, and the effect of EGb761 on them was studied using the MTT and TUNEL assays. Its ability to modulate the activities of some antioxidant enzymes was tested in vitro. In addition, cataract was induced in rats through selenite injection, and the effect of EGb761 administration on the progression of cataract was studied using slit lamp examination. Ginkgo biloba was found to be an excellent antioxidant. It readily scavenges reactive oxygen and nitrogen radicals and inhibits oxidative modifications that occur to proteins in vitro. It enters intact cells and protects them from alloxan-mediated and light-mediated stress, and the nuclear DNA from single strand breaks. It also effectively inhibits chemically induced apoptosis. It does not modulate the activities of endogenous antioxidant enzymes, nor does it have any significant antimicrobial activity. Unlike some other plant extracts, it is not phototoxic. In experiments wherein selenite cataract was induced in laboratory rats, treatment with the extract significantly retards the progression of lens opacification in vivo. Ginkgo biloba's inherent antioxidant, antiapoptotic and cytoprotective action and potential anticataract ability appear to be some of the factors responsible for its beneficial effects.

[1]  G. Spaeth,et al.  Complementary and alternative medicine for glaucoma. , 2001, Survey of ophthalmology.

[2]  E. Koch,et al.  Evidence for immunotoxic effects of crude Ginkgo biloba L. leaf extracts using the popliteal lymph node assay in the mouse. , 2000, International journal of immunopharmacology.

[3]  P. Le Bars,et al.  Efficacy and safety of a Ginkgo biloba extract , 2000, Public Health Nutrition.

[4]  J. I. Clark,et al.  Inhibition of lens opacification during the early stages of cataract formation. , 1995, Investigative ophthalmology & visual science.

[5]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.

[6]  B. Ahlemeyer,et al.  Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. , 1999, European journal of pharmacology.

[7]  H. Zhang,et al.  Insulinoma cells in culture show pronounced sensitivity to alloxan-induced oxidative stress , 1995, Diabetologia.

[8]  A. El-Fattah,et al.  Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: effect of ginkgo biloba extract. , 1995, Pharmacological research.

[9]  C. Sundari,et al.  Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. , 2001, Experimental eye research.

[10]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[11]  I. Fridovich,et al.  The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. , 1972, The Journal of biological chemistry.

[12]  K. Schey,et al.  Photooxidation of Lens α-Crystallin by Hypericin (Active Ingredient in St. John's Wort)¶ , 2000 .

[13]  S. Pietri,et al.  Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion , 2000, Basic Research in Cardiology.

[14]  R. D. Richards,et al.  Prevention of selenite cataract by vitamin C. , 1991, Experimental eye research.

[15]  L. Packer,et al.  [46] Antioxidant action of Ginkgo biloba extract EGb 761 , 1994 .

[16]  John I. Clark,et al.  Effect of selected anti-cataract agents on opacification in the selenite cataract model. , 1996, Experimental eye research.

[17]  J. Goosey,et al.  PHOTOSENSITIZED OXIDATION IN THE OCULAR LENS: EVIDENCE FOR PHOTOSENSITIZERS ENDOGENOUS TO THE HUMAN LENS , 1981, Photochemistry and photobiology.

[18]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[19]  P. Braquet,et al.  [Effect of Ginkgo biloba extract on the electrophysiology of the isolated retina from a diabetic rat]. , 1986, Presse medicale.

[20]  R. Ritch.  Potential role for Ginkgo biloba extract in the treatment of glaucoma. , 2000, Medical hypotheses.

[21]  R. W. Young.  Age-Related Cataract , 1990 .

[22]  L. Packer,et al.  Antioxidant action of Ginkgo biloba extract EGb 761. , 1994, Methods in enzymology.

[23]  P. Braquet,et al.  Effet de l'extrait de Ginkgo biloba sur l'électrophysiologie de la rétine isolée de rat diabétique. , 1986 .

[24]  K. Köse,et al.  Lipoperoxidation Induced by Hydrogen Peroxide in Human Erythrocyte Membranes. 1. Protective Effect of Ginkgo Biloba Extract (EGb 761) , 1995, The Journal of international medical research.

[25]  D. Lebuisson,et al.  [Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study]. , 1986, Presse medicale.

[26]  P. Guptasarma,et al.  Hydroxyl radical mediated damage to proteins, with special reference to the crystallins. , 1992, Biochemistry.

[27]  C. Juárez,et al.  Experimental Retinopathy of Prematurity: Angiostatic Inhibition by Nimodipine, Ginkgo-Biloba, and Dipyridamole, and Response to Different Growth Factors , 2000, European journal of ophthalmology.

[28]  J. Gorrand,et al.  Functional protection of photoreceptors from light-induced damage by dimethylthiourea and Ginkgo biloba extract. , 1999, Investigative ophthalmology & visual science.

[29]  M. Droy-lefaix,et al.  Modification of reperfusion-induced ionic imbalance by free radical scavengers in spontaneously hypertensive rat retina. , 1992, Free radical biology & medicine.

[30]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.

[31]  P. Riesz,et al.  A STUDY OF THE PHOTODYNAMIC EFFICIENCIES OF SOME EYE LENS CONSTITUENTS , 1991, Photochemistry and photobiology.

[32]  J. Evans.  Ginkgo biloba extract for age-related macular degeneration. , 2013, The Cochrane database of systematic reviews.

[33]  L. Flohé,et al.  Assays of glutathione peroxidase. , 1984, Methods in enzymology.

[34]  N. Luepke,et al.  Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET). , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  H. Sies,et al.  Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. , 1981, Methods in enzymology.

[36]  D. Garland,et al.  The effects of "oxygen radicals" generated in the medium on lenses in organ culture: inhibition of damage by chelated iron. , 1985, Archives of biochemistry and biophysics.

[37]  L. Packer,et al.  Different effects of the constituents of EGb761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals , 1999, Biochemistry and molecular biology international.

[38]  J. Westendorf,et al.  Induction of DNA strand-breaks in primary rat hepatocytes by ginkgolic acids. , 2000, Die Pharmazie.

[39]  R. Ritch,et al.  Ginkgo biloba extract increases ocular blood flow velocity. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[40]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[41]  L. Saso,et al.  Antimicrobial investigation of semipurified fractions of Ginkgo biloba leaves. , 2000, Journal of ethnopharmacology.

[42]  P. Braquet,et al.  Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. , 1991, Investigative ophthalmology & visual science.

[43]  H. Majumder,et al.  Luteolin, an Abundant Dietary Component is a Potent Anti-leishmanial Agent that Acts by Inducing Topoisomerase II-mediated Kinetoplast DNA Cleavage Leading to Apoptosis , 2000, Molecular medicine.

[44]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[45]  C. Rice-Evans,et al.  A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. , 1993, Clinical science.